{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:55:43Z","timestamp":1783695343330,"version":"3.55.0"},"reference-count":24,"publisher":"Portland Press Ltd.","issue":"2","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Objective: To study the effect of puerarin on electrophysiology using a hypertrophic cardiomyocyte (HC) model.<\/jats:p>\n               <jats:p>Materials and methods: Human urine epithelial cells were used to generate the HC model (hiPSC-CM). Cardiomyocyte hypertrophy was induced by applying 10 nM endothelin-1 (ET-1). Effects of puerarin pre-treatment (PPr) and post-treatment (PPo) on action potential, sodium current (INa) activation and inactivation, and recovery following INa inactivation were tested using patch clamp electrophysiology.<\/jats:p>\n               <jats:p>Results: Depolarization to repolarization 50% time (APD50) and repolarization 30% time (APD30) were significantly prolonged in the PPo and PPr groups compared with the controls. However, there were no significant differences in the action potential depolarization amplitude (APA) or the maximum depolarization velocity (Vmax) in phase 0. The PPr group had a slightly shortened APD90, and an extended APD50 and APD30, but did not exhibit any significant changes in stage A of APA and Vmax. The PPo group did not exhibit any significant changes in INa, while 12 h of PPr improved INa. However, puerarin did not significantly affect the activation, inactivation, or recovery of the sodium channel.<\/jats:p>\n               <jats:p>Conclusions: Cardiomyocyte hypertrophy significantly decreased the Vmax of the action potential and the peak density of INa. PPr inhibited the decrease in Vmax and increased the peak density of INa. Thus, puerarin could be used to stabilize the electrophysiological properties of hypertrophic cardiomyocytes and reduce arrhythmias.<\/jats:p>","DOI":"10.1042\/bsr20193369","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T15:10:07Z","timestamp":1580483407000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of puerarin on action potential and sodium channel activation in human hypertrophic cardiomyocytes"],"prefix":"10.1042","volume":"40","author":[{"given":"Yu-hui","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bin","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-wu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-wen","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jun","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-0457","authenticated-orcid":false,"given":"Xi-ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"2021111620014535700_B1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021111620014535700_B2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"2021111620014535700_B3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0165-6147(00)01524-8","article-title":"The human heart endothelin system: ET-1 synthesis, storage, release and effect","volume":"21","author":"Russell","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"2021111620014535700_B4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ. Res."},{"key":"2021111620014535700_B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cardiores.2005.05.015","article-title":"The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes","volume":"68","author":"Barac","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"2021111620014535700_B6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2006.08.078","article-title":"Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery","volume":"552","author":"Yeung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"2021111620014535700_B7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res."},{"key":"2021111620014535700_B8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11010-011-0746-0","article-title":"Puerarin: a novel antagonist to inward rectifier potassium channel (IK1)","volume":"352","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"2021111620014535700_B9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejphar.2007.07.018","article-title":"Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin","volume":"574","author":"Gao","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"2021111620014535700_B10","first-page":"787","article-title":"Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes","volume":"112","author":"Qian","year":"1999","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2021111620014535700_B11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2021111620014535700_B12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2021111620014535700_B13","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2021111620014535700_B14","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ. Res."},{"key":"2021111620014535700_B15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1582-4934.2009.00996.x","article-title":"Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells","volume":"15","author":"Germanguz","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"2021111620014535700_B16","doi-asserted-by":"publisher","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021111620014535700_B17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"2021111620014535700_B18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1681\/ASN.2011010106","article-title":"Generation of induced pluripotent stem cells from urine","volume":"22","author":"Zhou","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021111620014535700_B19","first-page":"1450","article-title":"Preclinical study on induction of pluripotent stem cells from urine of dilated cardiomyopathy patients","volume":"20","author":"Lin","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2021111620014535700_B20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/01.CIR.93.4.800","article-title":"Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation","volume":"93","author":"Cittadini","year":"1996","journal-title":"Circulation"},{"key":"2021111620014535700_B21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/287447a0","article-title":"Single Na+ channel currents observed in cultured rat muscle cells","volume":"287","author":"Sigworth","year":"1980","journal-title":"Nature"},{"key":"2021111620014535700_B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1254\/jphs.11038FP","article-title":"Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells","volume":"117","author":"Honda","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"2021111620014535700_B23","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3389\/fphys.2018.01406","article-title":"Eukaryotic Voltage-Gated Sodium Channels: On Their Origins, Asymmetries, Losses, Diversification and Adaptations","volume":"9","author":"Fux","year":"2018","journal-title":"Front Physiol."},{"key":"2021111620014535700_B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1540-8167.1993.tb01208.x","article-title":"Rapid inward current in ischemically-injured subepicardial myocytes bordering myocardial infarction","volume":"4","author":"Patterson","year":"1993","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20193369\/867800\/bsr-2019-3369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20193369\/867800\/bsr-2019-3369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:40:31Z","timestamp":1637095231000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/2\/BSR20193369\/222020\/Effect-of-puerarin-on-action-potential-and-sodium"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,28]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20193369","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,2]]},"article-number":"BSR20193369"}}